Rob E. Carpenter

752 total citations
47 papers, 513 citations indexed

About

Rob E. Carpenter is a scholar working on Molecular Biology, Epidemiology and Education. According to data from OpenAlex, Rob E. Carpenter has authored 47 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Education. Recurrent topics in Rob E. Carpenter's work include Urinary Tract Infections Management (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and SARS-CoV-2 detection and testing (4 papers). Rob E. Carpenter is often cited by papers focused on Urinary Tract Infections Management (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and SARS-CoV-2 detection and testing (4 papers). Rob E. Carpenter collaborates with scholars based in United States, United Kingdom and India. Rob E. Carpenter's co-authors include Etsuro K. Motoyama, Mary Rabb, Charles M. Haberkern, Peter J. Davis, Leila G. Welborn, Jerrold Lerman, Jody K. Takemoto, Leanne Coyne, Stephen A. Bustin and Paul J. Jenkins and has published in prestigious journals such as SHILAP Revista de lepidopterología, Anesthesiology and Frontiers in Cellular and Infection Microbiology.

In The Last Decade

Rob E. Carpenter

41 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob E. Carpenter United States 10 189 112 93 69 52 47 513
Margaret McIntyre United Kingdom 7 211 1.1× 88 0.8× 135 1.5× 5 0.1× 24 0.5× 17 440
Jochen Brich Germany 10 13 0.1× 29 0.3× 23 0.2× 48 0.7× 74 1.4× 22 407
Neha Singh India 10 49 0.3× 5 0.0× 103 1.1× 5 0.1× 291 5.6× 57 593
A. Bonnet France 10 30 0.2× 7 0.1× 106 1.1× 2 0.0× 59 1.1× 25 474
Jill L. Maron United States 16 18 0.1× 10 0.1× 57 0.6× 7 0.1× 128 2.5× 50 674
Zhiwei Zeng China 13 6 0.0× 20 0.2× 28 0.3× 6 0.1× 194 3.7× 38 609
Janelle Noel‐MacDonnell United States 12 10 0.1× 6 0.1× 112 1.2× 3 0.0× 52 1.0× 49 335
Duncan Cole United Kingdom 12 8 0.0× 4 0.0× 150 1.6× 15 0.2× 63 1.2× 35 498
Piyush Ranjan India 15 11 0.1× 4 0.0× 279 3.0× 14 0.2× 40 0.8× 74 793
Robert Dunlop United Kingdom 9 20 0.1× 5 0.0× 130 1.4× 3 0.0× 39 0.8× 20 531

Countries citing papers authored by Rob E. Carpenter

Since Specialization
Citations

This map shows the geographic impact of Rob E. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob E. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob E. Carpenter more than expected).

Fields of papers citing papers by Rob E. Carpenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob E. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob E. Carpenter. The network helps show where Rob E. Carpenter may publish in the future.

Co-authorship network of co-authors of Rob E. Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of Rob E. Carpenter. A scholar is included among the top collaborators of Rob E. Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob E. Carpenter. Rob E. Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carpenter, Rob E., et al.. (2025). Evaluation of direct-to-PCR (D2P) method for molecular diagnosis of infectious diseases. Experimental and Molecular Pathology. 143. 104972–104972. 2 indexed citations
2.
Carpenter, Rob E., et al.. (2025). Streamlining fungal diagnostics: Evaluation of a Direct-to-PCR extraction-free workflow for candida detection. Diagnostic Microbiology and Infectious Disease. 113(2). 116923–116923. 1 indexed citations
3.
Carpenter, Rob E., et al.. (2025). Diaper-based diagnostics: A novel non-invasive method for urine collection and molecular testing of uropathogens. Diagnostic Microbiology and Infectious Disease. 113(2). 116939–116939.
4.
Carpenter, Rob E.. (2025). Candida tropicalis in the diabetic urinary tract: Biofilm resistance, genomic plasticity, and public health implications. Diagnostic Microbiology and Infectious Disease. 113(3). 117005–117005.
5.
Carpenter, Rob E., et al.. (2025). Dataset for comparative analysis of precision metagenomics and traditional methods in urinary tract infection diagnostics. Data in Brief. 59. 111339–111339. 1 indexed citations
6.
Carpenter, Rob E., et al.. (2024). Dataset for a validated method of non-invasive urine collection using sodium polyacrylate-based diapers for PCR detection of uropathogens. Data in Brief. 57. 111036–111036. 2 indexed citations
7.
Carpenter, Rob E.. (2024). Navigating the new norm: The FDA's final rule on laboratory developed tests (LDTs) and its impact on clinical laboratory operations. Clinical Microbiology Newsletter. 48. 1–8. 2 indexed citations
8.
Carpenter, Rob E., et al.. (2023). Mentorship reconsidered: A case study of K-12 teachers’ mentor-mentee relationships during the COVID-19 pandemic. Social Psychology of Education. 26(5). 1269–1288. 6 indexed citations
9.
10.
Carpenter, Rob E., et al.. (2023). Deciphering Microbiota of Acute Upper Respiratory Infections: A Comparative Analysis of PCR and mNGS Methods for Lower Respiratory Trafficking Potential. Advances in respiratory medicine. 91(1). 49–65. 7 indexed citations
11.
Carpenter, Rob E., et al.. (2023). Advantage of precision metagenomics for urinary tract infection diagnostics. Frontiers in Cellular and Infection Microbiology. 13. 1221289–1221289. 18 indexed citations
12.
Carpenter, Rob E., et al.. (2023). SARS-CoV-2 Next Generation Sequencing (NGS) data from clinical isolates from the East Texas Region of the United States. Data in Brief. 49. 109312–109312. 3 indexed citations
13.
Robbins, Brian L., et al.. (2022). Analysis of D- and L- Isomers of (Meth)amphetamine in Human K2EDTA Plasma. Trends journal of sciences research. 3(1). 1–12. 1 indexed citations
14.
Carpenter, Rob E., et al.. (2022). COVIDSeq as Laboratory Developed Test (LDT) for Diagnosis of SARSCoV- 2 Variants of Concern (VOC). Archives of Clinical and Biomedical Research. 6(6). 954–970. 6 indexed citations
15.
Robbins, Brian L., et al.. (2022). A Human Oral Fluid Assay for D‐ and L- Isomer Detection of Amphetamine and Methamphetamine Using Liquid‐Liquid Extraction. Journal of Analytical Methods in Chemistry. 2022(1). 4819599–4819599. 5 indexed citations
16.
Carpenter, Rob E.. (2021). Learning as cognition: a developmental process for organizational learning. Development in Learning Organizations An International Journal. 35(6). 18–21. 6 indexed citations
17.
Carpenter, Rob E., et al.. (2021). The Student Engagement Effect of Team-Based Learning on Student Pharmacists. American Journal of Pharmaceutical Education. 86(5). 8567–8567. 12 indexed citations
18.
Carpenter, Rob E., et al.. (2020). The impact of team-based learning on the critical thinking skills of pharmacy students. Currents in Pharmacy Teaching and Learning. 13(2). 116–121. 52 indexed citations
19.
Srirangalingam, Umasuthan, Bernard Khoo, Matthew Matson, et al.. (2010). SDHD-Related Chromaffin Tumours: Disease Localisation to Genetic Dysfunction. Hormone Research in Paediatrics. 73(2). 135–139. 4 indexed citations
20.
Davies, Nathan, Graeme Moir, Rob E. Carpenter, et al.. (1991). ERICA predicts response to tamoxifen in elderly women with breast cancer.. Annals of The Royal College of Surgeons of England. 73(6). 361–3. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret McIntyre Breakdown of academic impact, for papers by Jochen Brich Breakdown of academic impact, for papers by Neha Singh Breakdown of academic impact, for papers by A. Bonnet Breakdown of academic impact, for papers by Jill L. Maron Breakdown of academic impact, for papers by Zhiwei Zeng Breakdown of academic impact, for papers by Janelle Noel‐MacDonnell Breakdown of academic impact, for papers by Duncan Cole Breakdown of academic impact, for papers by Piyush Ranjan Breakdown of academic impact, for papers by Robert Dunlop
Rankless by CCL
2026